We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Online ordering will be unavailable from 17:00 GMT on Friday, April 25 until 17:00 GMT on Sunday, April 27 due to maintenance. We apologise for the inconvenience.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Although the exact pathophysiology of hepatic encephalopathy (HE) is not fully understood, for more than a century ammonia has been thought to play a critical role. However, the interpretation and utility of ammonia levels in patients with chronic liver disease (CLD) presenting with HE has been a long-standing source of confusion. It is a common belief in the emergency department and on the wards that a single elevated ammonia level in a patient with CLD can confirm the diagnosis of HE, and a normal level essentially rules it out. This confusion stems from the fact that early studies showed a correlation between degree of encephalopathy and the ammonia level, but numerous subsequent studies have shown that severely encephalopathic patients often have normal ammonia levels. This paper reviews the published literature on ammonia levels in patients with CLD in an attempt to clarify its value as a clinical decision-making tool in patients with suspected HE.
Wolff–Parkinson–White (WPW) syndrome with atrial fibrillation (AF) is a potentially life-threatening problem requiring rapid conversion to sinus rhythm. The most recent American Heart Association guidelines for the treatment of patients with WPW, published in conjunction with the 2000 Advanced Cardiac Life Support (ACLS) guidelines, suggests that intravenous amiodarone is a first-line therapy for AF–WPW; however the evidence suggests this is a potentially dangerous myth.
Back pain affects up to 80% of the general population at some time during their lives. It is one of the most expensive outpatient diseases in medicine and is generally a recurrent problem. Most patients have no serious underlying disease and are termed “uncomplicated.” A few patients will have very serious disease necessitating emergent intervention. The process of identifying those with serious disease from the vast majority of patients with uncomplicated back pain can be difficult.
Anatomic essentials
Acute low back pain refers to pain felt in the lumbosacral spine and paraspinal areas. The pain may originate from lumbosacral structures such as bones (lumbar vertebrae, sacrum and coccyx), intervertebral discs, joints (facet, sacroiliac), soft tissues (muscles, tendons, ligaments), vascular structures, and nervous tissue (spinal cord, nerve roots). Low back pain may also be referred from pelvic, retroperitoneal, and abdominal structures due to shared innervation.
The spinal cord is housed in the spinal column, a series of interconnected bones held in place by complex ligamentous and muscular structures. The spinal cord is surrounded by the dura mater and a series of potential spaces. These spaces are important to clinicians because infection and tumor can seed there. The adult spinal cord ends at approximately the L1–L2 junction. The nerve roots at the end of the spinal cord are known as the cauda equina (horse's tail).
There has been much debate as to whether magnesium, a well-tolerated, readily available and cheap therapy, should be used to treat patients with suspected myocardial infarction. Despite promising results from animal studies and small clinical trials conducted in the 1980s, two large recent trials have concluded that the once phenomenal treatment is ineffective. The story of magnesium for acute myocardial infarction is a lesson in medical humility.
Reliance on the accuracy of the pelvic examination is upheld in many medical textbooks, but review of the literature does not support the accuracy or reproducibility of this examination. That this “test” is useful for ruling out serious disease will be exposed for the myth that it is.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.